Biomedical Technologies Grant is sponsored by NSF Small Business Innovation Research (SBIR) Program. Focuses on biomedical technologies, including diagnostics, supporting small businesses in developing innovative solutions.

Biomedical Technologies Grant – Apply Today | NSF SBIR For proposal preparation and submission instructions, click here . The SBIR/STTR program looks forward to receiving the submission of new Project Pitches in response to the new solicitations beginning on Tuesday, June 2, 2026. Please direct any questions to sbir@nsf.

gov . Biomedical Technologies (BM) Biomedical Technologies (BM) The Biomedical Technologies topic aims to support the early-stage development of novel products, processes or services that will enable the delivery of high-quality, economically efficient healthcare.

Subtopics are not aimed at supporting or conducting clinical trials, clinical efficacy or safety studies, the development pre-clinical or clinical-stage drug candidates or medical devices, or work performed primarily for regulatory purposes. Limited studies with human subjects may be acceptable to the extent that they are performed in support of feasibility, such as proof-of-concept studies of early-stage technologies.

Proposals that request support for clinical studies will be deemed noncompliant with the SBIR/STTR solicitations and returned without review. BM2. Drug Delivery Methods BM3.

Materials for Biomedical Applications BM6. Other Biomedical Technologies Application process for Biomedical Technologies (BM) funding Eligibility for Biomedical Technologies (BM) funding + Your company must be a small business (fewer than 500 employees) located in the United States. At least 50% of your company’s equity must be owned by U.S. citizens or permanent residents.

NSF does not fund companies that are majority-owned by multiple venture capital firms, private equity firms, or hedge funds, to participate in SBIR and STTR. All funded work, including work done by consultants and contractors, needs to take place in the United States. The project’s principal investigator (tech lead) must be legally employed at least 20 hours a week by the company seeking funding.

The principal investigator doesn’t need any advanced degrees. The principal investigator needs to commit to at least one month (173 hours) of work on a funded project per six months of project duration. Evaluation Criteria: What We Look for When Evaluating Biomedical Technologies (BM) proposals + Take our project assessment to see if your work might be a good fit for NSF funding.

Engineering bacteria to treat skin disease Azitra, a small business funded by the National Science Foundation (NSF), is harnessing the microbiome to treat skin disease. To learn more visit: https://azitrainc.

com/ Blood cleansing device removes pathogens Path Ex is developing a device to remove pathogens from blood and treat drug-resistant bacteria and endotoxins from circulating blood, which could be used in the treatment of bacteremia and sepsis. To learn more visit: https://pathex. co/ We invest up to $2 million in seed funding and take zero equity.

We’re looking for companies that are transformative, high-risk, have a market pull, and are scaleable.